These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 35914624)
1. The opioid system in depression. Jelen LA; Stone JM; Young AH; Mehta MA Neurosci Biobehav Rev; 2022 Sep; 140():104800. PubMed ID: 35914624 [TBL] [Abstract][Full Text] [Related]
2. Targeting opioid dysregulation in depression for the development of novel therapeutics. Browne CA; Lucki I Pharmacol Ther; 2019 Sep; 201():51-76. PubMed ID: 31051197 [TBL] [Abstract][Full Text] [Related]
11. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. Ji RR; Zhang Q; Law PY; Low HH; Elde R; Hökfelt T J Neurosci; 1995 Dec; 15(12):8156-66. PubMed ID: 8613750 [TBL] [Abstract][Full Text] [Related]
13. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors. Zaveri NT; Journigan VB; Polgar WE ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572 [TBL] [Abstract][Full Text] [Related]
14. In major depression, increased kappa and mu opioid receptor levels are associated with immune activation. Al-Hakeim HK; Zeki Al-Fadhel S; Al-Dujaili AH; Maes M Acta Neuropsychiatr; 2020 Apr; 32(2):99-108. PubMed ID: 31753054 [TBL] [Abstract][Full Text] [Related]
15. Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice. Boutin H; Catherine A; Mackenzie ET; Jauzac P; Dauphin F Acta Neuropathol; 2007 Nov; 114(5):491-500. PubMed ID: 17676326 [TBL] [Abstract][Full Text] [Related]
16. Opioidergic modulation of ethanol self-administration in the ventral pallidum. Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714 [TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Donica CL; Awwad HO; Thakker DR; Standifer KM Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957 [TBL] [Abstract][Full Text] [Related]
18. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors. Homberg JR; Mul JD; de Wit E; Cuppen E Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777 [TBL] [Abstract][Full Text] [Related]
19. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors. Olianas MC; Concas D; Onali P Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046 [TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors. Falcon E; Browne CA; Leon RM; Fleites VC; Sweeney R; Kirby LG; Lucki I Neuropsychopharmacology; 2016 Aug; 41(9):2344-51. PubMed ID: 26979295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]